Canada to develop ability to make millions of vaccines domestically

Prime Minster Justin Trudeau announced today a plan to create the ability to produce millions of doses of Covid-19 shots at a plant in Montreal starting this summer.

This will secure a domestic supply of the crucial vaccine as global markets are dealing with delivery delays and protectionist measures.

The Royalmount facility owned by the National Research Council will start making the millions of doses of the future Novavax vaccine the PM said. It was submitted for Health Canada approval last Friday.

It shows 89.3 percent efficacy in late stage clinical trials.

Novavax was a biotech company at the forefront of developing new vaccines against influenza.

Canada has committed to buying at least 52 million doses of the 2 dose product from the company.